AU1116088A – Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
– Google Patents
AU1116088A – Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
– Google Patents
Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
Info
Publication number
AU1116088A
AU1116088A
AU11160/88A
AU1116088A
AU1116088A
AU 1116088 A
AU1116088 A
AU 1116088A
AU 11160/88 A
AU11160/88 A
AU 11160/88A
AU 1116088 A
AU1116088 A
AU 1116088A
AU 1116088 A
AU1116088 A
AU 1116088A
Authority
AU
Australia
Prior art keywords
thenoyl
oxindole
carboxamide
chloro
anhydrous
Prior art date
1987-02-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU11160/88A
Other versions
AU587736B2
(en
Inventor
Douglas John Meldrum Allen
Brian Thomas O’neill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-02-02
Filing date
1988-02-01
Publication date
1988-08-04
1988-02-01
Application filed by Pfizer Inc
filed
Critical
Pfizer Inc
1988-08-04
Publication of AU1116088A
publication
Critical
patent/AU1116088A/en
1989-08-24
Application granted
granted
Critical
1989-08-24
Publication of AU587736B2
publication
Critical
patent/AU587736B2/en
2008-02-01
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/04—Centrally acting analgesics, e.g. opioids
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AU11160/88A
1987-02-02
1988-02-01
Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
Ceased
AU587736B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
PCT/US1987/000201
WO1988005656A1
(en)
1987-02-02
1987-02-02
Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
USUS87/00201
1987-02-02
Publications (2)
Publication Number
Publication Date
AU1116088A
true
AU1116088A
(en)
1988-08-04
AU587736B2
AU587736B2
(en)
1989-08-24
Family
ID=22202263
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU11160/88A
Ceased
AU587736B2
(en)
1987-02-02
1988-02-01
Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
Country Status (42)
Country
Link
US
(1)
US5036099A
(en)
EP
(1)
EP0277738B1
(en)
JP
(1)
JPS63201184A
(en)
KR
(1)
KR900001422B1
(en)
CN
(1)
CN1022324C
(en)
AP
(1)
AP52A
(en)
AR
(1)
AR243182A1
(en)
AT
(1)
ATE73800T1
(en)
AU
(1)
AU587736B2
(en)
BG
(1)
BG51042A3
(en)
CA
(1)
CA1335590C
(en)
CS
(2)
CS265250B2
(en)
CY
(1)
CY1775A
(en)
DD
(1)
DD267490A5
(en)
DE
(1)
DE3869149D1
(en)
DK
(1)
DK44888A
(en)
EC
(1)
ECSP941082A
(en)
ES
(1)
ES2032955T3
(en)
FI
(1)
FI89598C
(en)
GR
(1)
GR3004200T3
(en)
HK
(1)
HK132695A
(en)
IE
(1)
IE60000B1
(en)
IL
(1)
IL85277A
(en)
IN
(1)
IN171799B
(en)
IS
(1)
IS1533B
(en)
LV
(1)
LV10252B
(en)
MA
(1)
MA21171A1
(en)
MY
(1)
MY102737A
(en)
NO
(1)
NO170581C
(en)
NZ
(1)
NZ223373A
(en)
OA
(1)
OA08710A
(en)
PH
(1)
PH26545A
(en)
PL
(1)
PL149550B1
(en)
PT
(1)
PT86675B
(en)
RO
(1)
RO105052B1
(en)
RU
(1)
RU2011381C1
(en)
SG
(1)
SG27994G
(en)
SI
(1)
SI8810183A8
(en)
UA
(1)
UA25898A1
(en)
WO
(1)
WO1988005656A1
(en)
YU
(1)
YU46766B
(en)
ZA
(1)
ZA88679B
(en)
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU601325B2
(en)
*
1988-04-13
1990-09-06
Pfizer Inc.
3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
AU601326B2
(en)
*
1988-04-13
1990-09-06
Pfizer Inc.
3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function
Families Citing this family (17)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
EP0365194B1
(en)
*
1988-10-18
1995-08-02
Pfizer Inc.
Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
US5118703A
(en)
*
1988-10-18
1992-06-02
Pfizer Inc.
Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
US5059693A
(en)
*
1989-10-06
1991-10-22
Pfizer Inc.
Process for making 3-aroyl-2-oxindole-1-carboxamides
US5008283A
(en)
*
1990-03-19
1991-04-16
Pfizer Inc.
Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A
(en)
*
1990-03-19
1991-04-09
Pfizer Inc.
Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A
(en)
*
1991-02-08
1992-06-16
Pfizer Inc.
Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2
(en)
*
1991-04-08
1994-12-01
Mack Chem Pharm
Pharmaceutical preparation for rectal administration, which contains a 2-oxindole-1-carboxamide derivative
AU7503496A
(en)
*
1995-12-19
1997-07-14
Pfizer Inc.
Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1
(en)
*
1996-08-21
1998-03-04
Pfizer Inc.
Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1
(en)
*
1998-11-25
2000-05-31
Bayer Ag
Crystal modification B of 8-cyan-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo- / 4.3.O / nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo 3-quinoline carboxylic acid
US7407195B2
(en)
2004-04-14
2008-08-05
William Berson
Label for receiving indicia having variable spectral emissivity values
US7651031B2
(en)
*
2004-10-25
2010-01-26
William Berson
Systems and methods for reading indicium
US7728726B2
(en)
*
2005-01-14
2010-06-01
William Berson
Radio frequency identification labels
US7931413B2
(en)
*
2005-01-14
2011-04-26
William Berson
Printing system ribbon including print transferable circuitry and elements
US7621451B2
(en)
*
2005-01-14
2009-11-24
William Berson
Radio frequency identification labels and systems and methods for making the same
US7619520B2
(en)
*
2005-01-14
2009-11-17
William Berson
Radio frequency identification labels and systems and methods for making the same
WO2019087191A1
(en)
2017-11-02
2019-05-09
Accurate Medical Therapeutics Ltd.
Embolization catheter with integral filter
Family Cites Families (7)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US3767653A
(en)
*
1971-06-28
1973-10-23
Squibb & Sons Inc
Thiazines
GB1532413A
(en)
*
1974-12-23
1978-11-15
Union International Co Ltd
Chenodeoxycholic acid
DE2613346C3
(en)
*
1976-03-29
1981-07-23
Diamalt AG, 8000 München
Monocline crystalline chenodeoxycholic acid and process for its preparation
GR850310B
(en)
*
1984-02-07
1985-06-05
Pfizer
US4556672A
(en)
*
1984-03-19
1985-12-03
Pfizer Inc.
3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
GR850669B
(en)
*
1984-03-19
1985-07-25
Pfizer
US4569942A
(en)
*
1984-05-04
1986-02-11
Pfizer Inc.
N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
1987
1987-02-02
UA
UA4614718A
patent/UA25898A1/en
unknown
1987-02-02
RO
RO140907A
patent/RO105052B1/en
unknown
1987-02-02
US
US07/460,137
patent/US5036099A/en
not_active
Expired – Lifetime
1987-02-02
WO
PCT/US1987/000201
patent/WO1988005656A1/en
active
IP Right Grant
1988
1988-01-25
DE
DE8888300561T
patent/DE3869149D1/en
not_active
Expired – Fee Related
1988-01-25
AT
AT88300561T
patent/ATE73800T1/en
not_active
IP Right Cessation
1988-01-25
EP
EP88300561A
patent/EP0277738B1/en
not_active
Expired – Lifetime
1988-01-25
ES
ES88300561T
patent/ES2032955T3/en
not_active
Expired – Lifetime
1988-01-27
IN
IN67/DEL/88A
patent/IN171799B/en
unknown
1988-01-28
AP
APAP/P/1988/000081A
patent/AP52A/en
active
1988-01-29
DK
DK044888A
patent/DK44888A/en
not_active
Application Discontinuation
1988-01-29
CA
CA000557662A
patent/CA1335590C/en
not_active
Expired – Fee Related
1988-02-01
PH
PH36441A
patent/PH26545A/en
unknown
1988-02-01
PL
PL1988270415A
patent/PL149550B1/en
unknown
1988-02-01
IL
IL8527788A
patent/IL85277A/en
not_active
IP Right Cessation
1988-02-01
PT
PT86675A
patent/PT86675B/en
not_active
IP Right Cessation
1988-02-01
AR
AR88309983A
patent/AR243182A1/en
active
1988-02-01
OA
OA59273A
patent/OA08710A/en
unknown
1988-02-01
BG
BG82816A
patent/BG51042A3/en
unknown
1988-02-01
AU
AU11160/88A
patent/AU587736B2/en
not_active
Ceased
1988-02-01
SI
SI8810183A
patent/SI8810183A8/en
not_active
IP Right Cessation
1988-02-01
NZ
NZ223373A
patent/NZ223373A/en
unknown
1988-02-01
KR
KR1019880000876A
patent/KR900001422B1/en
not_active
IP Right Cessation
1988-02-01
MA
MA21408A
patent/MA21171A1/en
unknown
1988-02-01
YU
YU18388A
patent/YU46766B/en
unknown
1988-02-01
DD
DD88312599A
patent/DD267490A5/en
not_active
IP Right Cessation
1988-02-01
ZA
ZA88679A
patent/ZA88679B/en
unknown
1988-02-02
CN
CN88100555A
patent/CN1022324C/en
not_active
Expired – Fee Related
1988-02-02
CS
CS88648A
patent/CS265250B2/en
unknown
1988-02-02
JP
JP63022675A
patent/JPS63201184A/en
active
Granted
1988-02-02
MY
MYPI88000091A
patent/MY102737A/en
unknown
1988-02-02
IS
IS3309A
patent/IS1533B/en
unknown
1988-09-29
NO
NO88884329A
patent/NO170581C/en
not_active
IP Right Cessation
1989
1989-07-18
IE
IE26988A
patent/IE60000B1/en
not_active
IP Right Cessation
1989-08-01
RU
SU894614718A
patent/RU2011381C1/en
not_active
IP Right Cessation
1989-08-01
FI
FI893647A
patent/FI89598C/en
not_active
IP Right Cessation
1991
1991-11-22
CS
CS913541A
patent/CS354191A3/en
unknown
1992
1992-03-31
GR
GR920400571T
patent/GR3004200T3/el
unknown
1993
1993-11-15
LV
LVP-93-1225A
patent/LV10252B/en
unknown
1994
1994-02-22
SG
SG27994A
patent/SG27994G/en
unknown
1994-05-05
EC
EC1994001082A
patent/ECSP941082A/en
unknown
1995
1995-08-24
HK
HK132695A
patent/HK132695A/en
not_active
IP Right Cessation
1996
1996-04-05
CY
CY177596A
patent/CY1775A/en
unknown
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU601325B2
(en)
*
1988-04-13
1990-09-06
Pfizer Inc.
3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
AU601326B2
(en)
*
1988-04-13
1990-09-06
Pfizer Inc.
3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function
Also Published As
Publication number
Publication date
IL85277A
(en)
1994-02-27
DK44888A
(en)
1988-08-03
NO170581B
(en)
1992-07-27
IL85277A0
(en)
1988-07-31
NO170581C
(en)
1992-11-04
NZ223373A
(en)
1989-06-28
FI89598B
(en)
1993-07-15
WO1988005656A1
(en)
1988-08-11
CN1022324C
(en)
1993-10-06
YU18388A
(en)
1989-10-31
BG51042A3
(en)
1993-01-15
ES2032955T3
(en)
1996-07-16
AR243182A1
(en)
1993-07-30
DE3869149D1
(en)
1992-04-23
IS3309A7
(en)
1988-08-03
CS354191A3
(en)
1992-04-15
LV10252A
(en)
1994-10-20
MA21171A1
(en)
1988-10-01
IS1533B
(en)
1994-01-28
US5036099A
(en)
1991-07-30
HK132695A
(en)
1995-09-01
PL270415A1
(en)
1988-12-08
IE880269L
(en)
1988-08-02
RU2011381C1
(en)
1994-04-30
CN88100555A
(en)
1988-08-17
NO884329L
(en)
1988-09-29
PL149550B1
(en)
1990-02-28
ECSP941082A
(en)
1994-12-15
AP52A
(en)
1989-09-16
SI8810183A8
(en)
1996-08-31
NO884329D0
(en)
1988-09-29
PT86675A
(en)
1988-03-01
CA1335590C
(en)
1995-05-16
SG27994G
(en)
1994-10-14
KR880009961A
(en)
1988-10-06
PT86675B
(en)
1992-07-31
ZA88679B
(en)
1989-09-27
RO105052B1
(en)
1994-12-01
EP0277738B1
(en)
1992-03-18
FI89598C
(en)
1993-10-25
JPS63201184A
(en)
1988-08-19
LV10252B
(en)
1995-04-20
JPH0576945B2
(en)
1993-10-25
PH26545A
(en)
1992-08-19
AP8800081A0
(en)
1987-11-01
CY1775A
(en)
1996-04-05
GR3004200T3
(en)
1993-03-31
IN171799B
(en)
1993-01-09
EP0277738A1
(en)
1988-08-10
MY102737A
(en)
1992-09-30
AU587736B2
(en)
1989-08-24
FI893647A0
(en)
1989-08-01
DK44888D0
(en)
1988-01-29
YU46766B
(en)
1994-05-10
DD267490A5
(en)
1989-05-03
IE60000B1
(en)
1994-05-18
CS64888A2
(en)
1988-08-16
UA25898A1
(en)
1999-02-26
ATE73800T1
(en)
1992-04-15
KR900001422B1
(en)
1990-03-09
OA08710A
(en)
1989-03-31
CS265250B2
(en)
1989-10-13
Similar Documents
Publication
Publication Date
Title
AU587736B2
(en)
1989-08-24
Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
HK1026699A1
(en)
2000-12-22
Crystalline form of omeprazole sodium salt
AU5474996A
(en)
1996-12-19
Novel crystalline forms of anhydrous 7-{(1alpha,5alpha, 6alpha)-6-amino-3-azabicyclo(3.1.0)hex-3-y1}-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3- carboxylic acid, methanesulfonic acid salt.
AU2337288A
(en)
1989-04-06
Crystalline beta-lactam hydrate
AU558429B2
(en)
1987-01-29
Crystalline, anhydrous sodium 19-deoxyaglycone dianemycin
AU525538B2
(en)
1982-11-11
Crystalline sodium cefamandole
EG18479A
(en)
1992-12-30
Process for preparing anhydrous crystalling sodium salt of 5-chloro-3-(2-thenoyl)-2 oxindole-1 carboxamide
ZA885263B
(en)
1989-03-29
Crystalline monohydrate of sodium n-(1h-tetrazol-5-yl)-1-phenoxy-4h-quinolizin-4-one-3-carboxamide
LV5721B4
(en)
1996-06-20
5-Chloro-3- (2-tenoyl-2-oxindole-1-carboxamide free crystalline sodium salt)
CS809187A1
(en)
1989-10-13
Sodium salt of carboxymethyl-/1-6/-beta-d-gluco-/1-3-beta-d-glucan
AU2332988A
(en)
1989-04-06
(2-thienyl-methyl)-thiourea derivatives
IE870467L
(en)
1988-08-24
Sodium salt of 2-nitro-1, 3-propanediol
AU2452888A
(en)
1989-05-25
Crystallisation of sodium oxalates
PL272875A3
(en)
1989-12-11
Method of obtaining pure sodium salt of 2-/2,6-dichloroanillin/-phenylacetic acid
RO102065B1
(en)
1992-07-05
Sodium salt cefotaxime obtaining method
SI0991641T1
(en)
2003-08-31
Crystalline form of omeprazole sodium salt
NO874298L
(en)
1987-10-14
PREPARATION OF STABLE CRYSTALLINE SODIUM ACETYLSALYSYLATE.
None